How to buy Lam Research (LRCX) stock from India

Yes, an Indian resident can buy Lam Research — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying is the easy 10%. The 90% that decides your outcome is tax, estate-tax exposure, and position sizing. LRCX has one detail that changed the entry math: the October 2024 10-for-1 split dragged one share from $700-plus down into the low triple digits. This is the short version.

The 30-second version

• Legal and simple. Buy LRCX via any India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). Whole shares or a fractional rupee amount.
• Memory-cycle leverage. LRCX is the world's leading etch and deposition equipment maker — concentrated exposure to NAND capex recovery and to HBM (high-bandwidth memory) packaging steps that are the bottleneck for AI accelerators.
• Dividend friction. LRCX pays a small dividend (roughly 1% yield). The US withholds 25% under DTAA when you file a W-8BEN; you reclaim it as a foreign tax credit via Form 67 today, and Form 44 from TY2026-27.
• India tax on gains: hold more than 24 months and pay 12.5% LTCG (no indexation); sell sooner and pay your slab rate. Section 112, not the friendlier 112A.
• The trap most miss: directly-held LRCX is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax, with no India-US treaty relief.
• If your thesis is "semis," SOXX and SMH already give you LRCX plus the whole supply chain — equipment, foundries, fabless, memory — with no single-name customer-concentration risk.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	LRCX / Nasdaq
How	India-facing platform (Vested, INDmoney) or global broker (IBKR, Rovia)
Minimum	A fraction of one share (fractional lets you invest an exact rupee amount)
Dividend	Yes — approx 1% yield, paid quarterly, 25% US withholding
India tax on gains	12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax risk	US-situs above $60k means up to 40%, no treaty relief
Annual compliance	Schedule FA every year you hold; Form 67 for dividend FTC

How to buy it — 3 steps

1. Open an account and finish KYC. Pick an India-facing platform (Vested, INDmoney) for a simple India-funded experience, or a global broker (Interactive Brokers, Rovia) for wider access. File your W-8BEN during onboarding — this is what cuts US dividend withholding from a punitive 30% to the treaty 25%. New to this? Start with how to invest in US stocks from India.
2. Fund it via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per financial year). 20% TCS applies above ten lakh rupees in a year — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
3. Place the order. After Lam's 10-for-1 split in October 2024, one share trades in the low triple digits instead of the pre-split $700-plus level — so a whole share is affordable, or buy a fractional rupee amount. The split changed the price tag, not the economics.

The tax that actually matters

LRCX pays a dividend, so you face two layers of Indian tax — one on dividend income each year, one on capital gains when you sell.

Dividends. Paid quarterly in USD. The US withholds 25% at source under the India-US DTAA once your W-8BEN is on file (without it, the default is 30%). India then taxes the gross dividend at your slab rate as "income from other sources." To avoid double tax, claim the 25% as a foreign tax credit by filing Form 67 before your ITR — moving to Form 44 from TY2026-27 under the new rules. Detail and screenshots in dividend withholding and Form 67.

Capital gains. Section 112, because foreign shares don't qualify for the gentler 112A treatment Indian-listed equity gets:

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to roughly 30% plus surcharge)
More than 24 months	Long-term	12.5%, no indexation

Worked example (post-split prices). Buy 10 shares at $80 when USD/INR is 86 → cost 68,800 rupees. Sell 28 months later at $120 when USD/INR is 88 → proceeds 1,05,600 rupees. Taxable gain 36,800 rupees; LTCG at 12.5% = 4,600 rupees. The gain is computed in rupees, so the move from 86 to 88 amplifies your reported gain even before the dollar price moves. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India.

The $60,000 estate-tax trap

Directly-held LRCX is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there's no credit or relief. The fix (holding through pooled or fund structures rather than direct shares) has to be a deliberate choice made before the position gets large. Full detail: the $60,000 estate-tax trap.

Buy the stock, or get Lam through an ETF?

If you want…	Best route
A concentrated bet on memory capex and HBM packaging	LRCX directly
"US semis will compound" exposure without single-name risk	SOXX or SMH — LRCX plus the rest of the chain
Broad US tech exposure where LRCX is a small slice	QQQ, VTI, or VOO
Zero dividend-tax paperwork on the position	A broad accumulating ETF held offshore — see ETF guide

LRCX sits inside QQQ, VTI and VOO as a small weight, and inside the semi-themed SOXX and SMH at materially larger weights. The themed semi ETFs are the closer substitute if your real thesis is "the equipment makers, foundries and memory players all benefit from the AI build-out" — you get LRCX alongside Applied Materials, ASML, KLA, TSMC and Nvidia in one ticker. Compare the routes in direct stocks vs US ETFs and best US ETFs for Indian investors; the broader case is in US ETFs for Indians.

The business in one screen

What it is: Lam Research makes the wafer-fab equipment that removes material (etch) and adds material (deposition) on a chip — the two most repeated steps in the entire fab process. It is the global number-one in conductor etch and one of the top two in deposition, with NAND memory historically its single biggest end market and HBM packaging now its fastest-growing one. Customer base is concentrated in three memory names (Samsung, SK Hynix, Micron) plus the leading-edge logic foundries.

Bull case	Bear case
NAND capex cycle turning up after a multi-year trough	Memory is a brutally cyclical end market — drawdowns are deep
HBM3e and HBM4 packaging needs more etch and deposition steps per wafer	US export controls on China keep widening; ~30% of revenue is at risk
AI-server memory intensity lifts both DRAM and HBM tool demand	Customer concentration — three memory buyers drive most of the upside
Services and installed-base revenue (50%+ of sales) smooths the cycle	AMAT and ASML competing for share in adjacent deposition and lithography steps
10-for-1 split widened the retail and index-fund holder base	Premium multiple already prices in a clean memory recovery

Exact valuation is in the live widget above — a cyclical leader whose multiple expands when memory turns and compresses fast when it doesn't.

Our take

Verdict: BUY — etch and deposition leader with concentrated leverage to two of the cleanest AI-era catalysts: NAND memory recovery and HBM packaging build-out.

• The right pick-and-shovel for AI memory. Every HBM3e and HBM4 stack needs more through-silicon-via etch and dielectric deposition than the generation before. LRCX gets paid per fab step, not per accelerator sold, which is a more durable claim on the build-out than backing a single chip designer.
• Memory cycle is finally turning. NAND capex spent three years in a trough; the trough is ending. LRCX's revenue and margins have historically compounded fastest in the first two years of a memory upcycle, and the installed-base services line cushions the floor when capex pauses.
• Split made it ownable. The October 2024 10-for-1 split brought the share price from the $700s into the low triple digits — meaningful for Indian retail buyers building a position over time, and arguably the reason index-tracking and ETF flow has firmed up. Sized as a high-conviction semi-equipment satellite, not a core holding, LRCX fits an Indian investor wanting concentrated AI-memory exposure without owning Samsung or SK Hynix directly.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Memory-cycle downturn: if NAND and DRAM capex pauses again, LRCX's revenue can fall 20-30% inside a single year — equipment orders are the most cyclical line in the semi stack.
• China export controls: the US continues to tighten what wafer-fab equipment can be shipped into China, and a meaningful slice of LRCX revenue is exposed; each escalation re-rates the multiple down.
• Customer concentration and capex timing: three memory names drive most of the upside; a single buyer pushing out an order by two quarters can swing a print. Adjacent share losses to Applied Materials in deposition, or to ASML in lithography-adjacent steps, would compound the pressure.
• Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.

Two things people forget

• Schedule FA: disclose LRCX in Schedule FA of your ITR every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. Because LRCX pays a dividend, you also need Form 67 (Form 44 from TY2026-27) to claim the 25% US withholding back. Use the Schedule FA helper.
• Position size: a single cyclical semi-equipment maker, however dominant in its niche, is not an index. Size LRCX as a high-conviction satellite, not a substitute for a broad ETF — and remember that SOXX or SMH already give you most of the thesis with a fraction of the single-name risk.

Bottom line

Buying LRCX from India is easy and legal. What needs thought isn't the buying — it's that LRCX is a Section-112 capital-gains play (12.5% after 24 months), a US-situs asset with a $60k estate-tax trap, a dividend payer with annual Form 67 paperwork, and a cyclical single name that needs disciplined position sizing. The post-split price tag finally makes whole-share accumulation realistic for Indian retail. If your real thesis is "AI memory and semi-equipment will compound," SOXX or SMH gives you the same exposure with one Schedule FA entry. For accounts and options, start at the US investing hub.

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.